Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure

ConclusionsEarly initiation of ACEIs/ARBs within 48  h of admission for hospitalized patients with AHF was not associated with adverse events and correlated with improved outcomes at 1 year from admission.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research